Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Onabotulinumtoxin A vs Kenalog for Chronic Pelvic Pain
NCT02369068Completed
- Start
- Aug 2015
- Primary completion
- Mar 2018
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, double-blind trial of botulinum toxin type A in chronic pelvic pain (CPP) (2 arms). Primary endpoints: Visual Analog Scale at 1 month, Brief Pain Inventory Severity at 1 month and 2 more. Started Aug 2015; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
chronic pelvic pain (CPP)
Beyond the preview
Go deeper on NCT02369068.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02369068.